Levetiracetam Tablet
Product Images NDC 27808-263

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 27808-263). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cranbury Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Formula (Levetiracetam Tablets 1)

FDA Label Image

750mg_120 (Levetiracetam Tablets 10)

This is a medication description for Levetiracetam, containing 750mg of the active ingredient per tablet. Dosage instructions can be found in the package insert. Pharmacists should dispense the medication in a tight, light-resistant container. The medication should be stored at controlled room temperature, between 20 and 25°C. The manufacturer is Zhefang Jingin Prarmaceutical Co., L. in Zhejang Province, PR China, and it is distributed by Tris Pharma, Inc. in Monmouth Junction, NJ. The medication is available in a bottle of 120 tablets and requires a prescription.*

FDA Label Image

1000mg_60 (Levetiracetam Tablets 11)

Each tablet contains Levitiracetam 1000mg. This medication is dispensed with a medication guide provided separately. The manufacturer is Zijang Jingein Prarmaceuteal Co, from Znejang Provice, PR China. The tablets should be stored in a light-resistant container with a child-resistant closure at a controlled room temperature of 20°-25°C (68°-77°F). The recommended dosage should be complied with.*

FDA Label Image

Figure 1 (Levetiracetam Tablets 2)

FDA Label Image

Figure2 (Levetiracetam Tablets 3)

This is a table showing the percentage of patients, possibly from a clinical trial, treated with placebo (111 patients) or Levetiracetam (105 patients) at a dose of 2000mg/day. The percentages are not fully readable due to some characters missing.*

FDA Label Image

Figure3 (Levetiracetam Tablets 4)

This appears to be a summary or table showing the percentage of patients in a study who were on a placebo treatment versus those on a treatment of Leveiractam at a dosage of 3000 mg. However, it is not clear what the percentages represent and there is a typo in the second drug name ("mye" instead of "mg"). Without more context or explanation, it is difficult to provide a more detailed description of the text.*

FDA Label Image

Figure4 (Levetiracetam Tablets 5)

FDA Label Image

Figure5 (Levetiracetam Tablets 6)

This text is not readable.*

FDA Label Image

Figure6 (Levetiracetam Tablets 7)

FDA Label Image

250mg_120 (Levetiracetam Tablets 8)

This is a medication label for Levetiracetam tablets. It includes information such as the active ingredient, dosage, NDC number, manufacturer, pharmacist recommendations, storage instructions, and medication guide. The tablets should be stored in a container with a child-resistant closure at a controlled room temperature. The medication is available in a 120-tablet container for prescription use only.*

FDA Label Image

500mg_120 (Levetiracetam Tablets 9)

Each tablet of this medicine contains Lovetracetam 500mg. The recommended dosage information can be found in the package insert or provided by a healthcare professional. This medicine should be dispensed in a container with a child-resistant closure to prevent misuse. It should be stored at controlled room temperature (20-25°C). Manufactured by Znojang Jingiin Prarmaceuteal Co, Ltd, in Zhejang Pavince, PR.Chna for T Pharma, Inc in Monmouth Juncton, NJ. The drug is Levitiracetam, USP, available only with a prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.